RegAlign, registered trade mark
Back to Trust Centre

Controlled document status

A repository file, historical version or synthetic-data label does not by itself mean a document is approved for public or customer reliance. Items remain unlinked until current evidence, wording, audience and explicit release authority are recorded.

Commercial and buyer collateral

Static repository copies are not treated as externally approved without a current asset-specific release record.

What is RegAlign / one-pager
Withheld — publication approval not evidenced

Reconcile product scope, maturity, claims and approved audience before external issue.

Buyer briefs
Withheld — publication approval not evidenced

Reconcile role terminology, product capability and current buyer-validation boundary before use.

Investor / pitch material
Withheld — publication approval not evidenced

Investor-facing claims require current commercial, value, readiness and financial evidence plus channel-specific approval.

Auditor runbook
Withheld — methodology release approval not evidenced

Verifier methodology may be used only after current interface, limitation and audience review; it is not independent assurance.

Trust and pilot diligence material

Current assurance evidence remains qualified in several domains; the former public distribution copies remain withheld.

RegAlign Trust Pack
Withheld — currentness and release review

Full claim and evidence reconciliation is required before external issue.

BCP outline
Withheld — operating evidence incomplete

Continuity and restore design require current configuration and representative exercise evidence.

Penetration-test scope
Internal plan — no completed independent test

A scope does not establish that independent testing has occurred or that the scope itself is approved for public issue.

Sub-processor information
Withheld — supplier/transfer evidence incomplete

Current supplier, access, location, transfer and notice evidence must be completed and approved.

Retention and deletion
Withheld — lifecycle evidence incomplete

Periods, backup residue and tested deletion/export behaviour remain evidence-dependent.

Synthetic sample outputs

Synthetic content can support buyer validation, but synthetic-data status does not itself create publication authority.

CMP / CRA / BRA samples
Withheld — sample-specific release review required

Confirm current methodology, terminology, output shape and product implementation alignment.

Board / regulator / breach samples
Withheld — sample-specific release review required

Confirm that examples remain synthetic, appropriately qualified and do not imply a regulator-approved format or production operating effectiveness.

Audit-trail sample
Withheld — integrity wording review required

Must preserve the retained legacy-chain limitation and avoid universal chain-validity claims.

Methodology material

Methodology files are substantive controlled content, not generic marketing collateral.

CMP / CRA / BRA methodologies
Withheld — substantive/publication review required

Confirm current legal/regulatory framing, product alignment and permitted disclosure.

Client / sanctions / fraud / TEF / cyber / business-continuity methodologies
Withheld — substantive/publication review required

Each methodology requires separate currentness and release assessment; framework presence is not evidence of live product completeness.

Value and economics material

Model outputs remain internal evidence unless external claim conditions are met.

Customer value model
Internal scenario evidence only

ROI, savings, capacity and economic outcomes are not realised or typical customer results without retained measured evidence and an approved claim.

Founder / development economics
Internal control material

Internal development-capital or founder-effort analysis is not buyer-facing product evidence by default.